Astrana Health's first quarter results demonstrate strong revenue growth and effective expansion strategies, particularly in the Care Partners segment and emerging markets. The company is successfully integrating acquisitions and preparing for future growth with favorable Medicare Advantage rates. However, challenges with medical cost trends, margin pressures, and potential regulatory impacts present risks that need to be managed. Overall, the positive aspects slightly outweigh the challenges.

Company Guidance -

Q2 2025

During the Astrana Health First Quarter 2025 Earnings Call, the company provided robust guidance and insights into its financial and operational performance. Astrana reported total revenue of $620.4 million, a 53% increase year-over-year, with a significant contribution from the Care Partners segment, which grew 57% to $600 million. The company achieved an adjusted EBITDA of $36.4 million, driven by organic growth and strategic acquisitions, including CHS, which contributed $95 million. Membership expanded to 910,000, with 38% now in full-risk contracts, accounting for 75% of capitated revenue. Astrana projects full-year revenue of $2.5 to $2.7 billion and adjusted EBITDA of $170 to $190 million. The company expects revenue between $615 million and $665 million and adjusted EBITDA of $45 million to $50 million for the second quarter. Furthermore, Astrana remains confident in its medium-term goal of at least $350 million in adjusted EBITDA by 2027, supported by continued strategic acquisitions and enhancements in its AI-enabled technology infrastructure.

Significant Revenue Growth

Astrana Health reported a total revenue of $620.4 million, representing a 53% increase compared to the prior year period.

Strong Performance of Care Partners Segment

The Care Partners segment grew by 57% year over year to $600 million, driving the company's revenue growth.

Expansion in Emerging Markets

In Nevada and Texas, Astrana Health achieved significant growth and operational execution, with Nevada reaching breakeven and membership in the risk-bearing network growing by 40%.

Increased Membership in Full-Risk Arrangements

Approximately 38% of members are now in full-risk contracts, up from 5.5% a year ago, accounting for 75% of capitated revenue.

Successful CHS Integration

CHS integration is complete with over $10 million in G&A efficiencies identified, and performance in line with expectations.

Upcoming Prospect Health Acquisition

The planned acquisition of Prospect Health is expected to significantly expand the provider network and contribute $81 million in adjusted EBITDA with $12 million to $15 million in synergies.

Positive Medicare Advantage Rate Notice

The 2026 Medicare Advantage rate notice is favorable and expected to support continued growth and profitability.

Astrana Health (ASTH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

ASTH Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Aug 07, 2025	2025 (Q2)	0.35 / -	0.4	―	―	―
May 08, 2025	2025 (Q1)	0.21 / 0.14	0.31	-54.84% (-0.17)
Feb 27, 2025	2024 (Q4)	0.10 / -0.15	0.26	-157.69% (-0.41)
Nov 07, 2024	2024 (Q3)	0.31 / 0.33	0.47	-29.79% (-0.14)
Aug 07, 2024	2024 (Q2)	0.39 / 0.40	0.28	42.86% (+0.12)
May 07, 2024	2024 (Q1)	0.30 / 0.31	0.31	0.00% (0.00)
Feb 27, 2024	2023 (Q4)	0.15 / 0.26	-0.06	533.33% (+0.32)
Nov 07, 2023	2023 (Q3)	0.33 / 0.47	0.56	-16.07% (-0.09)
Aug 07, 2023	2023 (Q2)	0.25 / 0.28	0.25	12.00% (+0.03)
May 08, 2023	2023 (Q1)	0.31 / 0.31	0.31	0.00% (0.00)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

ASTH Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
May 08, 2025	$33.44	$29.71	-11.15%
Feb 27, 2025	$34.68	$25.38	-26.82%
Nov 07, 2024	$59.08	$46.96	-20.51%
Aug 07, 2024	$46.36	$46.85	+1.06%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Astrana Health Inc. (ASTH) report earnings?

Astrana Health Inc. (ASTH) is schdueled to report earning on Aug 07, 2025, TBA (Confirmed).

What is Astrana Health Inc. (ASTH) earnings time?

Astrana Health Inc. (ASTH) earnings time is at Aug 07, 2025, TBA (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is ASTH EPS forecast?

ASTH EPS forecast for the fiscal quarter 2025 (Q2) is 0.35.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing